Ifp Advisors, Inc Beyond Spring Inc. Transaction History

Ifp Advisors, Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 12, 2022	SELL	$4.02 - $16.84 $401 - $1,684	-100 Closed	0 $0
Q3 2021 Oct 06, 2021	SELL	$9.26 - $31.31 $8,778 - $29,681	-948 Reduced 90.46%	100 $2,000
Q2 2021 Jul 13, 2021	SELL	$9.37 - $12.12 $534 - $690	-57 Reduced 5.16%	1,048 $11,000
Q1 2021 Apr 30, 2021	SELL	$10.61 - $15.77 $137 - $205	-13 Reduced 1.16%	1,105 $11,000
Q4 2020 Jan 25, 2021	BUY	$10.21 - $17.31 $3,195 - $5,418	313 Added 38.88%	1,118 $14,000
Q3 2020 Oct 29, 2020	BUY	$9.99 - $16.13 $8,041 - $12,984	805 New	805 $11,000

5.55M

26K

2.4K

Ticker BYSI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,928,900
Market Cap $66.6M
Description
BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has completed Phase III clinical trials for the prevention of chemotherapy-induced neutropenia; and...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.